Navigation Links
Quest Diagnostics Launches National Electronic Health Records Awareness Tour Showcasing Care360 EHR

MADISON, N.J., March 22, 2011 /PRNewswire/ -- Later this month, Quest Diagnostics (NYSE: DGX) will demonstrate how physicians can benefit from $39 billion in federal incentives by utilizing Care360™ EHR. The 12-week, 10-city Care360 EHR Road Test tour was developed to help hospitals and physician practices across the nation experience first-hand the operational and financial benefits of electronic health records and Care360 EHR.

(Photo: )

To stimulate EHR adoption among ambulatory practices, Quest Diagnostics is taking its Care360 EHR solution directly to practice locations – allowing physicians and their staff to better understand the benefits and impact to their practice prior to implementing an EHR.

The Care360 EHR Road Test tour will provide healthcare professionals with a live, interactive demonstration of Care360 EHR software and the opportunity to learn from industry experts about EHR benefits for physicians, patients and other healthcare practitioners.

Featuring a state-of-the-art, 38-foot tour bus equipped with learning stations, the tour will provide visitors with insights on EHR features and functionality, including Clinical Decision Support (CDS), ePrescribing, secure messaging and Care360 EHR iPad® and iPhone® applications. Physicians will learn how they can access Care360 EHR at home, in the office, or at the hospital using the latest mobile devices and explore technology that can enable "virtual office visits" for their patients.

"Having access to complete patient data at the time of care is the most important feature of an EHR because it allows physicians to make more informed decisions and improves the coordination of care by securely sharing patient information with other care providers," said Richard A. Mahoney, vice president of healthcare information solutions for Quest Diagnostics and president of its healthcare IT subsidiary, MedPlus. "Our Care360 suite of products was developed for physicians by physicians, and we have more than 165,000 enrolled physicians using Care360.  We have been enhancing the Care360 platform for more than eight years and understand the importance of easy adoption at a pace that does not negatively impact patient visits or office workflow."

The Care360 EHR Road Test bus tour is planned to visit the following cities: Houston, TX; Dallas, TX; Phoenix, AZ; Tampa, FL; Miami, FL; Raleigh, NC; Fairfax, VA; Baltimore, MD; Philadelphia, PA, and New York, NY.

Physicians and hospital executives can view the current tour schedule or request a bus tour visit at

According to experts, adoption of Electronic Health Records is expected to accelerate as federal incentive programs make healthcare providers eligible to receive up to $44,000 over five years for successful implementation of a qualified EHR and demonstration of using the EHR in a meaningful way.

About Quest Diagnostics

Quest Diagnostics is the world's leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at

About Care360 EHR

Care360 is certified as a Complete EHR by the Certification Commission for eligible Health Information Technology (CCHIT®). More than 165,000 enrolled physicians at more than 75,000 locations across the nation rely on the Care360 suite of products to help improve patient care and increase practice efficiencies. For those physicians using Care360 Labs & Meds for online lab ordering/results and ePrescribing, the transition to Care360 EHR is simple, building upon their existing Care360 platform. Additional company information is available at

Glen Brandow
Quest Diagnostics
973-520-2800 (media)

SOURCE Quest Diagnostics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children
2. VioQuest Pharmaceuticals Completes Enrollment of Phase I Trial of Lenocta(TM)
3. Two Point of Care Tests From Quest Diagnostics Receive FDA 510(k) Clearance
4. Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease
5. VioQuest Pharmaceuticals Announces Dosing of First Patient in Phase IIa Solid Tumor Study for Lenocta(TM), a Novel Protein Tyrosine Phosphatase Inhibitor
6. Centocor and Janssen-Cilag Submit Applications Requesting Approval of Ustekinumab in the U.S. and Europe for Treatment of Moderate to Severe Plaque Psoriasis
7. U.S. Patent Office Rejects Key HIV/AIDS Drug Patents at PUBPAT Request: Government Finds Prior Art Submitted By PUBPAT Invalidates All of Gilead Sciences Claims
8. Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes
9. CSL Behring Submits BLA Requesting Approval of C1-Esterase Inhibitor for the Treatment of Hereditary Angioedema
10. BRAVE-3 Questions Value of Abciximab in PCI for Heart Attack
11. ImQuest Publishes Results of Important Structure Activity Relationship Program on Dual Acting Pyrimidinediones
Post Your Comments:
(Date:10/12/2015)... Given the intricacy of the anatomy and physiology of ... drug effectively to a specific ocular site. Several barriers have ... include dilution of a drug by tears, clearance of a ... issues with respect to the cornea, sclera and choroid. Approximately ... due to the aforementioned barriers. --> Given ...
(Date:10/12/2015)... and CRANBURY, N.J. , ... Arroyo LLP announces that a securities fraud ... Court for the District of New Jersey.  The complaint ... (NASDAQGM: FOLD) violated the Securities Exchange Act of 1934 ... making materially false and misleading statements about Amicus Therapeutics, ...
(Date:10/12/2015)...  Millions of smokers worldwide have used vaping to ... An April 2015 study released by a ... cigarettes to be up to 95 percent less harmful ... after the technology was first introduced the potentially harmful ... --> --> Palm Beach Vapors, ...
Breaking Medicine Technology:
(Date:10/13/2015)... ... October 13, 2015 , ... ... Debbie Vereb has been named the organization’s Executive Vice President of Operations, and ... hired to key leadership roles in the company. , Debbie Vereb’s appointment to ...
(Date:10/13/2015)... ... 13, 2015 , ... Curly Hair Solutions® is thrilled to ... an exhibition featuring the newest products and services to hit the market for ... more excited to unveil their recent partnership with Trade Secrets, a leading Canadian ...
(Date:10/13/2015)... , ... October 13, 2015 ... ... LLC presented results from GyencoloGeneTM, the world’s first commercially-available next-generation sequencing laboratory ... FIGO World Congress of Gynecology and Obstetrics in Vancouver, BC, Canada. ...
(Date:10/13/2015)... NY (PRWEB) , ... October 13, 2015 , ... ... her award winning programs Elder Care Doula Training and End of Life ... elderly in a holistic model, physically, spiritually and emotionally. Based on her ...
(Date:10/12/2015)... ... October 13, 2015 , ... Career Step, ... the release of its new Professional Medical Coding and Billing with Applied PCS ... ICD-10-CM and ICD-10-PCS code sets, earn the Certified Professional Coder (CPC) and Certified ...
Breaking Medicine News(10 mins):